JAK-STAT Pathway

Advertisement

cGxPJobs Banner

InnoCare Reports Positive Phase II Soficitinib Results

Beijing, July 16, 2026 InnoCare Pharma announced that the Phase II portion of its adaptive Phase II/III clinical trial...

By cGxPwire Editor
July 18, 2026

Read More

Advertisement

cGxPJobs

Directory